| Multidisease testing for HIV and TB using the GeneXpert platform: A feasibility study in rural Zimbabwe Z Ndlovu, E Fajardo, E Mbofana, T Maparo, D Garone, C Metcalf, ... PloS one 13 (3), e0193577, 2018 | 98 | 2018 |
| Engineering a sustainable future for point-of-care diagnostics and single-use microfluidic devices AE Ongaro, Z Ndlovu, E Sollier, C Otieno, P Ondoa, A Street, ... Lab on a Chip 22 (17), 3122-3137, 2022 | 60 | 2022 |
| Diagnostic performance and usability of the VISITECT CD4 semi-quantitative test for advanced HIV disease screening Z Ndlovu, L Massaquoi, NE Bangwen, JN Batumba, RU Bora, J Mbuaya, ... Plos one 15 (4), e0230453, 2020 | 32 | 2020 |
| Performance of Cepheid Xpert HIV-1 viral load plasma assay to accurately detect treatment failure JA Sacks, Y Fong, MP Gonzalez, M Andreotti, S Baliga, N Garrett, ... Aids 33 (12), 1881-1889, 2019 | 30 | 2019 |
| Framework for the implementation of advanced HIV disease diagnostics in sub-Saharan Africa: programmatic perspectives Z Ndlovu, R Burton, R Stewart, H Bygrave, T Roberts, E Fajardo, A Mataka, ... The Lancet HIV 7 (7), e514-e520, 2020 | 27 | 2020 |
| Novel FujiLAM assay to detect tuberculosis in HIV-positive ambulatory patients in four African countries: a diagnostic accuracy study H Huerga, M Bastard, AV Lubega, M Akinyi, NT Antabak, L Ohler, ... The Lancet Global Health 11 (1), e126-e135, 2023 | 26 | 2023 |
| Feasibility of using Determine TB-LAM to diagnose tuberculosis in HIV-positive patients in programmatic conditions: a multisite study SC Mathabire Rucker, L Cossa, RE Harrison, J Mpunga, S Lobo, ... Global health action 12 (1), 1672366, 2019 | 23 | 2019 |
| Patient and health-care worker experiences of an HIV viral load intervention using SMS: A qualitative study E Venables, Z Ndlovu, D Munyaradzi, G Martínez-Pérez, E Mbofana, ... PLoS One 14 (4), e0215236, 2019 | 20 | 2019 |
| Incidence and predictors of recovery from anaemia within an HIV-infected South African Cohort, 2004-2010 Z Ndlovu, T Chirwa, S Takuva Pan African Medical Journal 19 (1), 2014 | 20 | 2014 |
| Clinical utility of target-based next-generation sequencing for drug-resistant TB H Mansoor, N Hirani, V Chavan, M Das, J Sharma, M Bharati, V Oswal, ... The International Journal of Tuberculosis and Lung Disease 27 (1), 41-48, 2023 | 14 | 2023 |
| Delivering PrEP to young women in a low-income setting in South Africa: lessons for providing both convenience and support T Cassidy, N Ntuli, C Kilani, N Malabi, B Rorwana, T Mutseyekwa, ... AIDS and Behavior, 1-13, 2021 | 14 | 2021 |
| Scaling up HIV viral load monitoring in Manicaland, Zimbabwe: challenges and opportunities from the field B Nyagadza, N Kudya, E Mbofana, S Masaka, D Garone, CY Chen, ... Public Health Action 9 (4), 177-181, 2019 | 11 | 2019 |
| Feasibility and acceptability of using the novel urine-based FujiLAM test to detect tuberculosis: A multi-country mixed-methods study SCM Rücker, P Lissouba, M Akinyi, AV Lubega, R Stewart, NT Antabak, ... Journal of Clinical Tuberculosis and Other Mycobacterial Diseases 27, 100316, 2022 | 6 | 2022 |
| Operationalising targeted next-generation sequencing for routine diagnosis of drug-resistant TB A Iyer, Z Ndlovu, J Sharma, H Mansoor, M Bharati, S Kolan, M Morales, ... Public Health Action 13 (2), 43-49, 2023 | 5 | 2023 |
| Lay testing cadres and point-of-care diagnostic tests for HIV and other diseases: An essential combination in health service delivery Z Ndlovu, T Ellman PLoS Medicine 18 (11), e1003867, 2021 | 5 | 2021 |
| Framework for the implementation of advanced HIV disease diagnostics in sub-Saharan Africa: programmatic perspectives. Lancet HIV. 2020 Z Ndlovu, R Burton, R Stewart, H Bygrave, T Roberts, E Fajardo N= 500 n (%) Chloroquine N= 500 n (%) No prophylaxis N= 499 n (%) Total N …, 0 | 5 | |
| Pilot assessment of the diagnostic accuracy of Cepheid GeneXpert HIV-1 Qual for early infant diagnosis J Bitilinyu-Bangoh, R Khunga, R Ortuño, A Shigayeva, C Metcalf, ... AIDS, 2016 | 2 | 2016 |
| From equitable access to equitable innovation: rethinking bioengineering for global health A Street, M Kersaudy Kerhoas, Z Ndlovu Nature Reviews Bioengineering 2 (6), 444-446, 2024 | 1 | 2024 |
| Diagnostic accuracy of the novel FujiLAM assay to detect tuberculosis in HIV-positive ambulatory patients from four African countries H Huerga, M Bastard, AV Lubega, M Akinyi, N Tamayo Antabak, L Ohler, ... | 1 | 2022 |
| Clinical utility of target-based next-generation sequencing for drug-resistant tuberculosis: a pilot from Mumbai, India H Mansoor, N Hirani, VV Chavan, A Joshi, V Oswal, J Sharma, AS Iyer, ... MSF Scientific Days International 2022, 2022 | | 2022 |
Gilles Van CutsemHonorary Research Associate, Centre for Infectious Disease Epidemiology and Research, University of Cape Town & Resident in Neurology, University of Luxembourg在 pm.me 的电子邮件经过验证
